Rank | Gene Set | Z-score |
---|---|---|
1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.93811845 |
2 | epoxygenase P450 pathway (GO:0019373) | 9.84810222 |
3 | exogenous drug catabolic process (GO:0042738) | 9.23878268 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63116214 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.63116214 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29929961 |
7 | L-phenylalanine metabolic process (GO:0006558) | 7.29929961 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.91121706 |
9 | ethanol metabolic process (GO:0006067) | 6.90827285 |
10 | drug metabolic process (GO:0017144) | 6.48866942 |
11 | tryptophan catabolic process (GO:0006569) | 6.29992944 |
12 | indole-containing compound catabolic process (GO:0042436) | 6.29992944 |
13 | indolalkylamine catabolic process (GO:0046218) | 6.29992944 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.29878027 |
15 | oxidative demethylation (GO:0070989) | 6.29160333 |
16 | kynurenine metabolic process (GO:0070189) | 6.12358064 |
17 | bile acid biosynthetic process (GO:0006699) | 5.95991441 |
18 | tryptophan metabolic process (GO:0006568) | 5.91740668 |
19 | glyoxylate metabolic process (GO:0046487) | 5.77712738 |
20 | urea cycle (GO:0000050) | 5.71994041 |
21 | urea metabolic process (GO:0019627) | 5.71994041 |
22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60739475 |
23 | negative regulation of fibrinolysis (GO:0051918) | 5.57733428 |
24 | regulation of plasminogen activation (GO:0010755) | 5.52330478 |
25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.50997844 |
26 | regulation of fibrinolysis (GO:0051917) | 5.41587472 |
27 | protein carboxylation (GO:0018214) | 5.37866752 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37866752 |
29 | cysteine metabolic process (GO:0006534) | 5.36593075 |
30 | sulfur amino acid catabolic process (GO:0000098) | 5.31558010 |
31 | regulation of protein activation cascade (GO:2000257) | 5.29878211 |
32 | complement activation, alternative pathway (GO:0006957) | 5.29027201 |
33 | nitrogen cycle metabolic process (GO:0071941) | 5.26460581 |
34 | phenylpropanoid metabolic process (GO:0009698) | 5.23295303 |
35 | serine family amino acid catabolic process (GO:0009071) | 5.21647286 |
36 | opsonization (GO:0008228) | 5.15016374 |
37 | bile acid metabolic process (GO:0008206) | 5.10753602 |
38 | aromatic amino acid family metabolic process (GO:0009072) | 5.01796207 |
39 | regulation of complement activation (GO:0030449) | 4.93316476 |
40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91258890 |
41 | regulation of cholesterol esterification (GO:0010872) | 4.87315110 |
42 | tyrosine metabolic process (GO:0006570) | 4.81038102 |
43 | reverse cholesterol transport (GO:0043691) | 4.79811134 |
44 | homocysteine metabolic process (GO:0050667) | 4.79145340 |
45 | negative regulation of blood coagulation (GO:0030195) | 4.76957601 |
46 | negative regulation of hemostasis (GO:1900047) | 4.76957601 |
47 | regulation of humoral immune response (GO:0002920) | 4.76239302 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 4.75476315 |
49 | protein-lipid complex remodeling (GO:0034368) | 4.74961179 |
50 | macromolecular complex remodeling (GO:0034367) | 4.74961179 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.74961179 |
52 | S-adenosylmethionine metabolic process (GO:0046500) | 4.73697212 |
53 | amino-acid betaine metabolic process (GO:0006577) | 4.65622195 |
54 | * alpha-amino acid catabolic process (GO:1901606) | 4.63639915 |
55 | lysine catabolic process (GO:0006554) | 4.62105044 |
56 | lysine metabolic process (GO:0006553) | 4.62105044 |
57 | negative regulation of protein activation cascade (GO:2000258) | 4.60640470 |
58 | acute-phase response (GO:0006953) | 4.59399209 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.59218295 |
60 | negative regulation of sterol transport (GO:0032372) | 4.59218295 |
61 | triglyceride homeostasis (GO:0070328) | 4.59184824 |
62 | acylglycerol homeostasis (GO:0055090) | 4.59184824 |
63 | phospholipid efflux (GO:0033700) | 4.55132634 |
64 | alkaloid metabolic process (GO:0009820) | 4.54851981 |
65 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.52278427 |
66 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.52278427 |
67 | glycine metabolic process (GO:0006544) | 4.48916954 |
68 | cellular ketone body metabolic process (GO:0046950) | 4.45883591 |
69 | indolalkylamine metabolic process (GO:0006586) | 4.45711207 |
70 | bile acid and bile salt transport (GO:0015721) | 4.43216662 |
71 | coenzyme catabolic process (GO:0009109) | 4.41201933 |
72 | amine catabolic process (GO:0009310) | 4.40769295 |
73 | cellular biogenic amine catabolic process (GO:0042402) | 4.40769295 |
74 | negative regulation of coagulation (GO:0050819) | 4.33326022 |
75 | plasma lipoprotein particle clearance (GO:0034381) | 4.32569303 |
76 | negative regulation of wound healing (GO:0061045) | 4.28667345 |
77 | cellular glucuronidation (GO:0052695) | 4.28392749 |
78 | * cellular amino acid catabolic process (GO:0009063) | 4.26418017 |
79 | serine family amino acid metabolic process (GO:0009069) | 4.23968038 |
80 | cholesterol efflux (GO:0033344) | 4.18731612 |
81 | benzene-containing compound metabolic process (GO:0042537) | 4.18002741 |
82 | positive regulation of hemostasis (GO:1900048) | 4.15117969 |
83 | positive regulation of blood coagulation (GO:0030194) | 4.15117969 |
84 | ethanol oxidation (GO:0006069) | 4.13300801 |
85 | cellular modified amino acid catabolic process (GO:0042219) | 4.10743025 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07901701 |
87 | arginine metabolic process (GO:0006525) | 4.06592650 |
88 | serine family amino acid biosynthetic process (GO:0009070) | 4.06511545 |
89 | * glutamate metabolic process (GO:0006536) | 4.03257199 |
90 | aldehyde catabolic process (GO:0046185) | 4.03035750 |
91 | fibrinolysis (GO:0042730) | 4.02295981 |
92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98655625 |
93 | plasma lipoprotein particle assembly (GO:0034377) | 3.98624660 |
94 | drug catabolic process (GO:0042737) | 3.96344563 |
95 | negative regulation of complement activation (GO:0045916) | 3.91536359 |
96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91059348 |
97 | ketone body metabolic process (GO:1902224) | 3.85921925 |
98 | * imidazole-containing compound metabolic process (GO:0052803) | 3.82073296 |
99 | cofactor catabolic process (GO:0051187) | 3.81565753 |
100 | uronic acid metabolic process (GO:0006063) | 3.81097436 |
101 | glucuronate metabolic process (GO:0019585) | 3.81097436 |
102 | positive regulation of coagulation (GO:0050820) | 3.80307475 |
103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79403317 |
104 | complement activation, classical pathway (GO:0006958) | 3.74606592 |
105 | * carboxylic acid catabolic process (GO:0046395) | 3.74569100 |
106 | * organic acid catabolic process (GO:0016054) | 3.74569100 |
107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73084734 |
108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73084734 |
109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72725002 |
110 | protein activation cascade (GO:0072376) | 3.72501293 |
111 | negative regulation of lipase activity (GO:0060192) | 3.72468485 |
112 | complement activation (GO:0006956) | 3.71238066 |
113 | cholesterol homeostasis (GO:0042632) | 3.71148215 |
114 | phospholipid homeostasis (GO:0055091) | 3.70482857 |
115 | short-chain fatty acid metabolic process (GO:0046459) | 3.70361100 |
116 | positive regulation of lipid catabolic process (GO:0050996) | 3.69549462 |
117 | acetyl-CoA metabolic process (GO:0006084) | 3.66335928 |
118 | NAD biosynthetic process (GO:0009435) | 3.65850137 |
119 | sterol homeostasis (GO:0055092) | 3.64836747 |
120 | regulation of cholesterol homeostasis (GO:2000188) | 3.62066911 |
121 | intestinal cholesterol absorption (GO:0030299) | 3.61646110 |
122 | plasma lipoprotein particle organization (GO:0071827) | 3.61211106 |
123 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59991358 |
124 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59991358 |
125 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.59757889 |
126 | flavonoid metabolic process (GO:0009812) | 3.59652069 |
127 | cytolysis (GO:0019835) | 3.58415142 |
128 | xenobiotic metabolic process (GO:0006805) | 3.51466450 |
129 | regulation of apoptotic cell clearance (GO:2000425) | 3.48540904 |
130 | acute inflammatory response (GO:0002526) | 3.44683978 |
131 | hormone catabolic process (GO:0042447) | 3.44170827 |
132 | sodium-independent organic anion transport (GO:0043252) | 3.44007845 |
133 | regulation of acute inflammatory response (GO:0002673) | 3.41021186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46498839 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24564255 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10479166 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49256874 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31137926 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18917927 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82271200 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.08958406 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01125816 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07375383 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01368597 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0150596 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93075165 |
14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53906470 |
15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48085777 |
16 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43708890 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39323568 |
18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39068114 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29171845 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22735767 |
21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21417426 |
22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19729938 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09418440 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08250934 |
25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08104741 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07563949 |
27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03458329 |
28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03049941 |
29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02398316 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87563746 |
31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86695631 |
32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86364606 |
33 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85360543 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84254807 |
35 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.83240934 |
36 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82777576 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80302837 |
38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79094103 |
39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78177595 |
40 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76950331 |
41 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76362798 |
42 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75779369 |
43 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75552048 |
44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74028511 |
45 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73967180 |
46 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72687897 |
47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71165782 |
48 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.70722442 |
49 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70478393 |
50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69870925 |
51 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.67681609 |
52 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66821744 |
53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66788420 |
54 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.66231685 |
55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64975582 |
56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64839543 |
57 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64511528 |
58 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.63989449 |
59 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63766933 |
60 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.63568254 |
61 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63566522 |
62 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63331899 |
63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63025707 |
64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63006748 |
65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62605217 |
66 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.62155549 |
67 | NFYA_21822215_ChIP-Seq_K562_Human | 0.62123392 |
68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60635558 |
69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60635558 |
70 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.60527594 |
71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.60288406 |
72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.60160835 |
73 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59395691 |
74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59108969 |
75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.59045008 |
76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.58527035 |
77 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.58177705 |
78 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57249211 |
79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57186586 |
80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.56587462 |
81 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.56481369 |
82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56086201 |
83 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55682101 |
84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55014025 |
85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54776915 |
86 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.54494399 |
87 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54326918 |
88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53700855 |
89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53002142 |
90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.52725465 |
91 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.52576466 |
92 | SA1_27219007_Chip-Seq_Bcells_Human | 0.52563691 |
93 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.52336114 |
94 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52062201 |
95 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51129483 |
96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50921724 |
97 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50906704 |
98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50863813 |
99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.50349305 |
100 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50273220 |
101 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.49844176 |
102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49365144 |
103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48501190 |
104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48281902 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47937663 |
106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47494450 |
107 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47152544 |
108 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46510796 |
109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.46304750 |
110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.46152414 |
111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.46053375 |
112 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44789608 |
113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44193419 |
114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44052616 |
115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42959991 |
116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42639216 |
117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42222103 |
118 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.41524776 |
119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40793026 |
120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40669497 |
121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40651804 |
122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40289177 |
123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38962925 |
124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.38331521 |
125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.37967497 |
126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37278058 |
127 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36625035 |
128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35850485 |
129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.35538650 |
130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.35017358 |
131 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34704854 |
132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34602131 |
133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.34385053 |
134 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34342675 |
135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33484377 |
136 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.32503131 |
137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.32183021 |
138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.31724157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.30433203 |
2 | MP0005360_urolithiasis | 7.56981652 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.42548843 |
4 | MP0005365_abnormal_bile_salt | 6.15290720 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13911080 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.28755103 |
7 | MP0003252_abnormal_bile_duct | 3.91460164 |
8 | MP0010329_abnormal_lipoprotein_level | 3.56139667 |
9 | MP0009840_abnormal_foam_cell | 3.22558307 |
10 | MP0005083_abnormal_biliary_tract | 3.09596764 |
11 | MP0003195_calcinosis | 2.90685899 |
12 | MP0005332_abnormal_amino_acid | 2.80397053 |
13 | MP0001666_abnormal_nutrient_absorption | 2.56659897 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.27811724 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.17251231 |
16 | MP0000609_abnormal_liver_physiology | 2.16695798 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.08864453 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.00883595 |
19 | MP0003868_abnormal_feces_composition | 1.98004381 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84002092 |
21 | MP0001764_abnormal_homeostasis | 1.69525275 |
22 | MP0009697_abnormal_copulation | 1.62386029 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59099948 |
24 | MP0005451_abnormal_body_composition | 1.44375657 |
25 | MP0003011_delayed_dark_adaptation | 1.37629878 |
26 | MP0003186_abnormal_redox_activity | 1.29481964 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.27949344 |
28 | MP0009643_abnormal_urine_homeostasis | 1.26529815 |
29 | MP0000598_abnormal_liver_morphology | 1.18234064 |
30 | MP0005647_abnormal_sex_gland | 1.14914727 |
31 | MP0009764_decreased_sensitivity_to | 1.10269650 |
32 | MP0009763_increased_sensitivity_to | 1.03846407 |
33 | MP0000604_amyloidosis | 1.01688195 |
34 | MP0002282_abnormal_trachea_morphology | 1.01644146 |
35 | MP0002254_reproductive_system_inflammat | 0.99205602 |
36 | MP0005636_abnormal_mineral_homeostasis | 0.97867024 |
37 | MP0003705_abnormal_hypodermis_morpholog | 0.96577642 |
38 | MP0010368_abnormal_lymphatic_system | 0.94392054 |
39 | MP0008469_abnormal_protein_level | 0.93940280 |
40 | MP0009642_abnormal_blood_homeostasis | 0.89007218 |
41 | MP0002876_abnormal_thyroid_physiology | 0.88275258 |
42 | MP0005084_abnormal_gallbladder_morpholo | 0.86023569 |
43 | MP0006036_abnormal_mitochondrial_physio | 0.85280870 |
44 | MP0005408_hypopigmentation | 0.84606613 |
45 | MP0009765_abnormal_xenobiotic_induced | 0.79942423 |
46 | MP0005376_homeostasis/metabolism_phenot | 0.79739371 |
47 | MP0001915_intracranial_hemorrhage | 0.79727317 |
48 | MP0002249_abnormal_larynx_morphology | 0.79503047 |
49 | MP0002078_abnormal_glucose_homeostasis | 0.77220816 |
50 | MP0005220_abnormal_exocrine_pancreas | 0.74344215 |
51 | MP0005670_abnormal_white_adipose | 0.73145382 |
52 | MP0002971_abnormal_brown_adipose | 0.72986127 |
53 | MP0003879_abnormal_hair_cell | 0.71873145 |
54 | MP0001661_extended_life_span | 0.71603026 |
55 | MP0005334_abnormal_fat_pad | 0.69764131 |
56 | MP0009785_altered_susceptibility_to | 0.66611898 |
57 | MP0004130_abnormal_muscle_cell | 0.66321728 |
58 | MP0005535_abnormal_body_temperature | 0.66120051 |
59 | MP0005187_abnormal_penis_morphology | 0.64579694 |
60 | MP0005266_abnormal_metabolism | 0.64352061 |
61 | MP0003690_abnormal_glial_cell | 0.61062664 |
62 | MP0001756_abnormal_urination | 0.60521702 |
63 | MP0005464_abnormal_platelet_physiology | 0.59301573 |
64 | MP0003724_increased_susceptibility_to | 0.58705063 |
65 | MP0006035_abnormal_mitochondrial_morpho | 0.58617989 |
66 | MP0009053_abnormal_anal_canal | 0.58351699 |
67 | MP0000639_abnormal_adrenal_gland | 0.57849500 |
68 | MP0005448_abnormal_energy_balance | 0.54545122 |
69 | MP0003329_amyloid_beta_deposits | 0.54399961 |
70 | MP0003436_decreased_susceptibility_to | 0.53282509 |
71 | MP0004381_abnormal_hair_follicle | 0.50236385 |
72 | MP0002928_abnormal_bile_duct | 0.49533155 |
73 | MP0003718_maternal_effect | 0.49360550 |
74 | MP0005395_other_phenotype | 0.48853546 |
75 | MP0002136_abnormal_kidney_physiology | 0.48732054 |
76 | MP0000566_synostosis | 0.47971089 |
77 | MP0003638_abnormal_response/metabolism_ | 0.47767415 |
78 | MP0002822_catalepsy | 0.47533649 |
79 | MP0002332_abnormal_exercise_endurance | 0.47210965 |
80 | MP0008874_decreased_physiological_sensi | 0.45267271 |
81 | MP0008873_increased_physiological_sensi | 0.44444127 |
82 | MP0005023_abnormal_wound_healing | 0.44228769 |
83 | MP0004782_abnormal_surfactant_physiolog | 0.44035767 |
84 | MP0001986_abnormal_taste_sensitivity | 0.41108483 |
85 | MP0003953_abnormal_hormone_level | 0.40870342 |
86 | MP0003075_altered_response_to | 0.40412632 |
87 | MP0006082_CNS_inflammation | 0.37818111 |
88 | MP0001853_heart_inflammation | 0.37682749 |
89 | MP0005166_decreased_susceptibility_to | 0.37588304 |
90 | MP0008872_abnormal_physiological_respon | 0.35550920 |
91 | MP0000579_abnormal_nail_morphology | 0.35236942 |
92 | MP0000467_abnormal_esophagus_morphology | 0.35236432 |
93 | MP0005666_abnormal_adipose_tissue | 0.34353074 |
94 | MP0005248_abnormal_Harderian_gland | 0.33860020 |
95 | MP0009115_abnormal_fat_cell | 0.33198582 |
96 | MP0001845_abnormal_inflammatory_respons | 0.33006670 |
97 | MP0000249_abnormal_blood_vessel | 0.32339714 |
98 | MP0000230_abnormal_systemic_arterial | 0.32224336 |
99 | MP0009672_abnormal_birth_weight | 0.32202429 |
100 | MP0002970_abnormal_white_adipose | 0.30904981 |
101 | MP0002837_dystrophic_cardiac_calcinosis | 0.30273787 |
102 | MP0002168_other_aberrant_phenotype | 0.29972991 |
103 | MP0002132_abnormal_respiratory_system | 0.29678439 |
104 | MP0001243_abnormal_dermal_layer | 0.29492792 |
105 | MP0009384_cardiac_valve_regurgitation | 0.29437211 |
106 | MP0006292_abnormal_olfactory_placode | 0.29046908 |
107 | MP0004883_abnormal_blood_vessel | 0.28436068 |
108 | MP0009379_abnormal_foot_pigmentation | 0.27844644 |
109 | MP0002796_impaired_skin_barrier | 0.27024261 |
110 | MP0005397_hematopoietic_system_phenotyp | 0.26808015 |
111 | MP0001545_abnormal_hematopoietic_system | 0.26808015 |
112 | MP0001881_abnormal_mammary_gland | 0.26475397 |
113 | MP0005058_abnormal_lysosome_morphology | 0.24691995 |
114 | MP0005164_abnormal_response_to | 0.23646180 |
115 | MP0001851_eye_inflammation | 0.22036266 |
116 | MP0003878_abnormal_ear_physiology | 0.17445615 |
117 | MP0005377_hearing/vestibular/ear_phenot | 0.17445615 |
118 | MP0002128_abnormal_blood_circulation | 0.16794950 |
119 | MP0001440_abnormal_grooming_behavior | 0.15870111 |
120 | MP0005197_abnormal_uvea_morphology | 0.15465247 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46996576 |
2 | Deep venous thrombosis (HP:0002625) | 7.33713496 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.23343160 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.79958877 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.39132219 |
6 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.26979511 |
7 | Xanthomatosis (HP:0000991) | 6.20861722 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.52252981 |
9 | Complement deficiency (HP:0004431) | 5.24608758 |
10 | Joint hemorrhage (HP:0005261) | 4.92846697 |
11 | Hypolipoproteinemia (HP:0010981) | 4.72017879 |
12 | Hyperammonemia (HP:0001987) | 4.59900684 |
13 | Hyperglycinemia (HP:0002154) | 4.55501312 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47992175 |
15 | Epidermoid cyst (HP:0200040) | 4.44899905 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32292677 |
17 | Abnormality of methionine metabolism (HP:0010901) | 4.28319722 |
18 | Ketosis (HP:0001946) | 4.26143718 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24441698 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.22165669 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15402725 |
22 | Fat malabsorption (HP:0002630) | 4.10650983 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 4.07594759 |
24 | Hyperglycinuria (HP:0003108) | 4.03247837 |
25 | Abnormality of glycine metabolism (HP:0010895) | 4.00045023 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.00045023 |
27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93006271 |
28 | Abnormality of complement system (HP:0005339) | 3.84175253 |
29 | Hypoglycemic coma (HP:0001325) | 3.82599354 |
30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77285136 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.73433124 |
32 | Hypercholesterolemia (HP:0003124) | 3.62029697 |
33 | Neonatal hypoglycemia (HP:0001998) | 3.54430817 |
34 | Hyperbilirubinemia (HP:0002904) | 3.43485012 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36862075 |
36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36637611 |
37 | Delayed CNS myelination (HP:0002188) | 3.19428297 |
38 | Abnormality of serum amino acid levels (HP:0003112) | 3.15666608 |
39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11125449 |
40 | Steatorrhea (HP:0002570) | 3.09076384 |
41 | Spontaneous abortion (HP:0005268) | 3.06970502 |
42 | Ketoacidosis (HP:0001993) | 3.00454491 |
43 | Myocardial infarction (HP:0001658) | 2.95439620 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.94262829 |
45 | Hypochromic microcytic anemia (HP:0004840) | 2.90977938 |
46 | Metabolic acidosis (HP:0001942) | 2.77838058 |
47 | Abnormality of purine metabolism (HP:0004352) | 2.70185037 |
48 | Skin nodule (HP:0200036) | 2.70110776 |
49 | Systemic lupus erythematosus (HP:0002725) | 2.69730354 |
50 | Lethargy (HP:0001254) | 2.66846733 |
51 | Vascular calcification (HP:0004934) | 2.65326035 |
52 | Dicarboxylic aciduria (HP:0003215) | 2.63643329 |
53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63643329 |
54 | Glomerulonephritis (HP:0000099) | 2.59001682 |
55 | Acanthocytosis (HP:0001927) | 2.58382207 |
56 | Osteomalacia (HP:0002749) | 2.56714051 |
57 | Purpura (HP:0000979) | 2.56612175 |
58 | Hypoglycemic seizures (HP:0002173) | 2.46926080 |
59 | Pulmonary embolism (HP:0002204) | 2.46130400 |
60 | Cerebral edema (HP:0002181) | 2.45759658 |
61 | Gout (HP:0001997) | 2.44612529 |
62 | Mitral stenosis (HP:0001718) | 2.41911007 |
63 | Spastic diplegia (HP:0001264) | 2.40822497 |
64 | Abnormal gallbladder morphology (HP:0012437) | 2.40730991 |
65 | Neonatal onset (HP:0003623) | 2.36935781 |
66 | Irritability (HP:0000737) | 2.36734677 |
67 | Cholelithiasis (HP:0001081) | 2.34279842 |
68 | Cardiovascular calcification (HP:0011915) | 2.33999004 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33453621 |
70 | Malnutrition (HP:0004395) | 2.32842523 |
71 | Amyloidosis (HP:0011034) | 2.30167765 |
72 | Gingival bleeding (HP:0000225) | 2.27559740 |
73 | Cholecystitis (HP:0001082) | 2.27116901 |
74 | Abnormal gallbladder physiology (HP:0012438) | 2.27116901 |
75 | Late onset (HP:0003584) | 2.24019724 |
76 | Menorrhagia (HP:0000132) | 2.23628687 |
77 | Pancreatitis (HP:0001733) | 2.17979633 |
78 | Esophageal varix (HP:0002040) | 2.15879684 |
79 | Thrombophlebitis (HP:0004418) | 2.13895970 |
80 | Brushfield spots (HP:0001088) | 2.13599331 |
81 | Generalized aminoaciduria (HP:0002909) | 2.12536324 |
82 | Vomiting (HP:0002013) | 2.10334073 |
83 | Enlarged kidneys (HP:0000105) | 2.09201603 |
84 | Opisthotonus (HP:0002179) | 2.08798783 |
85 | Sensorimotor neuropathy (HP:0007141) | 2.07875585 |
86 | Poikilocytosis (HP:0004447) | 2.05578753 |
87 | Hemorrhage of the eye (HP:0011885) | 2.01108122 |
88 | Arthropathy (HP:0003040) | 1.98978195 |
89 | Alkalosis (HP:0001948) | 1.96896408 |
90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96762878 |
91 | Rickets (HP:0002748) | 1.95829754 |
92 | Abnormality of the gallbladder (HP:0005264) | 1.95504090 |
93 | Increased serum ferritin (HP:0003281) | 1.95396841 |
94 | Abnormality of iron homeostasis (HP:0011031) | 1.93234634 |
95 | Hypophosphatemic rickets (HP:0004912) | 1.92453260 |
96 | Elevated alkaline phosphatase (HP:0003155) | 1.90461896 |
97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89930006 |
98 | Renal cortical cysts (HP:0000803) | 1.89796358 |
99 | Hyperphosphaturia (HP:0003109) | 1.89663876 |
100 | Reduced antithrombin III activity (HP:0001976) | 1.89180843 |
101 | Elevated hepatic transaminases (HP:0002910) | 1.87440794 |
102 | Abnormality of proline metabolism (HP:0010907) | 1.85130427 |
103 | Hydroxyprolinuria (HP:0003080) | 1.85130427 |
104 | Abnormality of the Achilles tendon (HP:0005109) | 1.84704979 |
105 | Increased mean platelet volume (HP:0011877) | 1.82907971 |
106 | Abnormal cartilage morphology (HP:0002763) | 1.82881995 |
107 | Gangrene (HP:0100758) | 1.81833965 |
108 | Epistaxis (HP:0000421) | 1.81314481 |
109 | Nephritis (HP:0000123) | 1.80496806 |
110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80014736 |
111 | Status epilepticus (HP:0002133) | 1.77399283 |
112 | Abnormality of vitamin metabolism (HP:0100508) | 1.74893342 |
113 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73389030 |
114 | Abnormality of urine glucose concentration (HP:0011016) | 1.73053542 |
115 | Glycosuria (HP:0003076) | 1.73053542 |
116 | Reticulocytosis (HP:0001923) | 1.70370418 |
117 | Joint swelling (HP:0001386) | 1.70361315 |
118 | Cerebral palsy (HP:0100021) | 1.70084101 |
119 | Bifid scrotum (HP:0000048) | 1.67762663 |
120 | Atrioventricular block (HP:0001678) | 1.66894163 |
121 | Abnormal platelet volume (HP:0011876) | 1.66222679 |
122 | Impaired platelet aggregation (HP:0003540) | 1.61076887 |
123 | Abnormal platelet function (HP:0011869) | 1.61076887 |
124 | Hypochromic anemia (HP:0001931) | 1.52931212 |
125 | Abnormal urine phosphate concentration (HP:0012599) | 1.52044014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.27606827 |
2 | SIK1 | 4.63108685 |
3 | FGFR4 | 4.61508560 |
4 | ERN1 | 4.33690456 |
5 | TAOK3 | 3.34113296 |
6 | INSRR | 3.03022883 |
7 | ERBB4 | 2.80396238 |
8 | PIK3CA | 2.42893509 |
9 | MAP2K4 | 2.22974762 |
10 | PRPF4B | 2.21799712 |
11 | FLT3 | 2.16877772 |
12 | PKN2 | 2.09063191 |
13 | MST1R | 2.08673141 |
14 | MAPK11 | 1.97833963 |
15 | PIK3CG | 1.92453868 |
16 | TYK2 | 1.83050725 |
17 | NTRK3 | 1.80550736 |
18 | DAPK2 | 1.53056582 |
19 | ABL2 | 1.51953274 |
20 | KDR | 1.46863023 |
21 | TRIB3 | 1.40910647 |
22 | NEK9 | 1.39367195 |
23 | TNK2 | 1.33576241 |
24 | PTK6 | 1.29631673 |
25 | LATS1 | 1.28919953 |
26 | PINK1 | 1.28643546 |
27 | JAK2 | 1.26210013 |
28 | PRKAA2 | 1.19996854 |
29 | TBK1 | 1.18552638 |
30 | MAP3K7 | 1.15639984 |
31 | MAP3K14 | 1.15586471 |
32 | FRK | 1.15427753 |
33 | MAPK4 | 1.11412969 |
34 | MAP2K3 | 1.09436659 |
35 | FGFR2 | 1.09239431 |
36 | GRK6 | 1.06446774 |
37 | JAK1 | 1.03483368 |
38 | IRAK3 | 1.03182991 |
39 | MAPK15 | 1.02442623 |
40 | PRKG1 | 1.01490962 |
41 | ERBB2 | 0.97663625 |
42 | TIE1 | 0.97483831 |
43 | PRKACA | 0.93166782 |
44 | ICK | 0.90061467 |
45 | MAP3K10 | 0.86636345 |
46 | BLK | 0.84386399 |
47 | PRKCZ | 0.83999328 |
48 | DYRK1B | 0.81983123 |
49 | MAPK12 | 0.81568230 |
50 | TGFBR2 | 0.79820608 |
51 | CSK | 0.79802280 |
52 | MAP3K11 | 0.79516388 |
53 | CDK6 | 0.78744162 |
54 | AKT3 | 0.77144205 |
55 | MAP2K6 | 0.76401019 |
56 | PDK2 | 0.76108959 |
57 | PRKACG | 0.73607195 |
58 | IKBKE | 0.72975522 |
59 | EPHA3 | 0.72402435 |
60 | CAMKK2 | 0.72182537 |
61 | CSF1R | 0.70844227 |
62 | NLK | 0.69373518 |
63 | STK38L | 0.69251526 |
64 | EPHB1 | 0.69098718 |
65 | FER | 0.68599033 |
66 | MAP3K3 | 0.67988992 |
67 | CAMKK1 | 0.67501954 |
68 | CAMK2G | 0.66393743 |
69 | PRKAA1 | 0.65396911 |
70 | GSK3A | 0.63599453 |
71 | CSNK1D | 0.62549966 |
72 | MET | 0.62283696 |
73 | RPS6KA3 | 0.59951733 |
74 | SGK3 | 0.55854515 |
75 | MAP3K2 | 0.55595131 |
76 | CAMK1D | 0.55348637 |
77 | PRKCB | 0.55094007 |
78 | TAOK2 | 0.54672511 |
79 | CSNK1G1 | 0.54559571 |
80 | SRC | 0.53829527 |
81 | SGK1 | 0.53489544 |
82 | MAPK7 | 0.53294230 |
83 | KIT | 0.49609839 |
84 | PRKACB | 0.49556023 |
85 | PRKCQ | 0.49242035 |
86 | GRK1 | 0.48538709 |
87 | SGK2 | 0.46778979 |
88 | FGFR3 | 0.45901455 |
89 | CDK4 | 0.45264481 |
90 | IRAK1 | 0.44319186 |
91 | MAP3K13 | 0.43863215 |
92 | MAP3K6 | 0.43766992 |
93 | IGF1R | 0.43531293 |
94 | SMG1 | 0.42291704 |
95 | IRAK2 | 0.41624576 |
96 | CSNK2A1 | 0.41040535 |
97 | MAPK3 | 0.40794580 |
98 | PDPK1 | 0.40689890 |
99 | CSNK1E | 0.40497873 |
100 | DYRK1A | 0.39322843 |
101 | MAP3K5 | 0.38875511 |
102 | PTK2 | 0.37766617 |
103 | EPHA4 | 0.37074593 |
104 | MYLK | 0.34619146 |
105 | MAP3K1 | 0.33754146 |
106 | CSNK2A2 | 0.33508893 |
107 | PRKCG | 0.33260753 |
108 | ARAF | 0.33235695 |
109 | CAMK4 | 0.33031987 |
110 | AKT2 | 0.32857610 |
111 | RIPK1 | 0.32466099 |
112 | TNIK | 0.30259842 |
113 | STK38 | 0.28421650 |
114 | STK16 | 0.28349482 |
115 | MAPK10 | 0.28126063 |
116 | EGFR | 0.27623160 |
117 | SGK494 | 0.26812489 |
118 | SGK223 | 0.26812489 |
119 | RET | 0.26798229 |
120 | PKN1 | 0.26352865 |
121 | MAP2K1 | 0.26102857 |
122 | CSNK1A1 | 0.25903346 |
123 | ABL1 | 0.25674836 |
124 | MAP2K2 | 0.25189044 |
125 | MAP4K1 | 0.24877784 |
126 | CSNK1G2 | 0.24868546 |
127 | CSNK1G3 | 0.24622503 |
128 | PRKCA | 0.24305703 |
129 | PDK1 | 0.23896158 |
130 | PBK | 0.21790602 |
131 | ZAP70 | 0.20488676 |
132 | MTOR | 0.19810042 |
133 | BTK | 0.19798880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50699777 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55419443 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40828252 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30258481 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06491269 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76722303 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72194170 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70267067 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62895911 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56521851 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47693033 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38821930 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33825878 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16474661 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14388786 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.10193125 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97694196 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96319411 |
19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95615908 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92303642 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84072069 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81695565 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79092359 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77876537 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73332941 |
26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73317616 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72182749 |
28 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.71756931 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71195930 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68740996 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60588254 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60460401 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54829190 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53229260 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49195003 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.48138683 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43356437 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34645451 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34012441 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33130344 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32023777 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29095707 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26322083 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.23965916 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19157883 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17103735 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13781449 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10596175 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04999710 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04729962 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04450797 |
52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03751958 |
53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01126251 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97037718 |
55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92823096 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91897740 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88791495 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84714638 |
59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82457598 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.80696960 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67855886 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66979216 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66265091 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57397993 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49937630 |
66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47287296 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42274356 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40117426 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.30458678 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25556547 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25130781 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22518241 |
73 | Insulin resistance_Homo sapiens_hsa04931 | 0.20589097 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20583067 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19803312 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15858606 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14011241 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06962826 |
79 | Amoebiasis_Homo sapiens_hsa05146 | 0.01331464 |
80 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2645229 |
81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2532244 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2449899 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2429597 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2425821 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2407595 |
86 | Pertussis_Homo sapiens_hsa05133 | -0.2362782 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2234651 |
88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2077830 |
89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2035239 |
90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2007736 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1830865 |
92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1797607 |
93 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1738622 |
94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1693219 |
95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1678139 |
96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1467843 |
97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1367645 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1338124 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1283470 |
100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1277252 |
101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1189555 |
102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1187797 |
103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0793066 |
104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0567965 |
105 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0507199 |
106 | Mineral absorption_Homo sapiens_hsa04978 | -0.0387594 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0312304 |
108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0240611 |
109 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0053590 |